Cardiovascular and Metabolic Disorders

Featured Article

Maternal Deaths in the United States: Sounding a Call to Action

Maternal Deaths in the United States: Sounding a Call to Action

Despite multiple measures and goals to reduce US maternal mortality rates, the latest data suggest the United States is far behind the rest of the world in maternal health care.

Latest

Metabolic Profile, Weight Increases Assessed in Ziprasidone Augmentation for Major Depressive Disorder

Metabolic Profile, Weight Increases Assessed in Ziprasidone Augmentation for Major Depressive Disorder

Escitalopram plus ziprasidone was found safe in certain patients, although the therapy required regular cardiovascular and metabolic monitoring.

Pediatric Respiratory and Atopic Outcomes With Free Sugar Consumption In Pregnancy

Pediatric Respiratory and Atopic Outcomes With Free Sugar Consumption In Pregnancy

Data from a UK cohort were used to examine the relationship between maternal sugar intake levels and pediatric respiratory and atopic outcomes.

Risk Factors for Preeclampsia and Pregnancy-Associated Stroke in Women

Risk Factors for Preeclampsia and Pregnancy-Associated Stroke in Women

Pregnancy-associated stroke risk is even higher in women with chronic hypertension, coagulopathies, and prothrombotic conditions.

Preventing Preterm Preeclampsia in At-Risk Women

Preventing Preterm Preeclampsia in At-Risk Women

Researchers examined the efficacy of aspirin in preventing preterm preeclampsia in women at risk.

Examining Health And Economic Burdens of Preeclampsia on Mothers, Children

Examining Health And Economic Burdens of Preeclampsia on Mothers, Children

Financial data for both mothers and children were examined through the first year of life.

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

Relationship Between Psoriasis and Cardiometabolic Comorbidities Examined

Comorbidities included hyperlipidemia, hypertension, and type 2 diabetes, among others.

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Major Adverse CV Event Prediction Via Coronary CT Angiography in T2D

Extent and severity of coronary artery disease was examined in over 900 patients with type 2 diabetes.

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

SGLT2 Inhibitors May Reduce Blood Pressure in Type 2 Diabetes

Sodium-glucose cotransporter 2 inhibitors reduced both systolic and diastolic blood pressure in patients with type 2 diabetes.

CV Event Risk Similar Regardless of Diabetes Diagnosis

CV Event Risk Similar Regardless of Diabetes Diagnosis

Statin and aspirin therapies in diabetes did not increased patients' risks of cardiovascular events.

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

FDA Approves Inclusion of LEADER Trial Data On Liraglutide Labeling

Data from the 9300 patient LEADER trial is now eligible for inclusion on liraglutide injection packaging.

Sign Up for Free e-Newsletters